Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Senior Director, Oligonucleotide Center of Excellence at Part of the Janssen Pharmaceutical Companies of Johnson & Johnson
Sergei M. Gryaznov, Ph.D., is an internationally recognized scientist and expert in the areas of oligonucleotide chemistry, telomerase, nucleosides, nucleotides, DNA & RNA analogues, and nucleic acid-derived therapeutic agents. Currently, Dr. Gryaznov is a Senior Director of Oligonucleotide Chemistry with Nucleic Acid Center of Excellence at Alios BioPharma, which is a part of the Janssen Pharmaceutical Companies. Prior to this appointment, he worked as the CTO of AuraSense Therapeutics, LLC (now Exicure Corp.), and before that as a Director of Chemistry and Senior Research Fellow with Geron Corporation, where he defined major scientific and drug-discovery directions for the companies.